Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD

Journal of Psychopharmacology

Volumn 29, Issue 1, 2015, Pages 31-38

  Kittel Schneider, Sarah ^a,b   Reuß, Martin ^c   Meyer, Andrea ^c   Weber, Heike ^c   Gessner, Alexandra ^c   Leistner, Carolin ^c   Kopf, Juliane ^a   Schmidt, Brigitte ^c   Hempel, Susanne ^c   Volkert, Julia ^a,c   Lesch, Klaus Peter ^c   Reif, Andreas ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

attention deficit hyperactivity disorder; biomarkers; bipolar disorder; genetic polymorphism; Nitric oxide

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MOOD STABILIZER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTONOMIC NERVOUS SYSTEM; BIPOLAR DISORDER; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NITRINERGIC SYSTEM; NOS1 GENE; NOS3 GENE; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT; BLOOD; GENETICS; HAPLOTYPE; MIDDLE AGED; YOUNG ADULT;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOLOGICAL MARKERS; BIOMARKERS; BIPOLAR DISORDER; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84918505589     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114555251     Document Type: Article

References (48)

1. Andreazza AC, Kauer-Sant'anna M, Frey BN, et al. Oxidative stress markers in bipolar disorder: A meta-analysis. J Affect Disord. 2008 ; 111: 135-144
2. Aspide R, Gironi Carnevale UA, Sergeant JA, et al. Non-selective attention and nitric oxide in putative animal models of Attention-Deficit Hyperactivity Disorder. Behav Brain Res. 1998 ; 95: 123-133
3. Bohme GA, Bon C, Stutzmann JM, et al. Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol. 1991 ; 199: 379-381
4. Cattaruzza M, Guzik TJ, Slodowski W, et al. Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease. Circ Res. 2004 ; 95: 841-847
5. Ceylan M, Sener S, Bayraktar AC, et al. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010 ; 34: 1491-1494
6. Christiansen H, Kis B, Hirsch O, et al. German validation of the Conners Adult ADHD Rating Scales (CAARS) II: Reliability, validity, diagnostic sensitivity and specificity. Eur Psychiatry. 2012 ; 27: 321-328
7. Daff S. Calmodulin-dependent regulation of mammalian nitric oxide synthase. Biochem Soc Trans. 2003 ; 31: 502-505
8. Leitfaden zur Erfassung des psychopathologischen Befundes. Halbstrukturiertes Interview anhand des AMDP-Systems. Fähndrich ESRD, ed. Berlin: Hogrefe ; 2007 :
9. Faul F, Erdfelder E, Lang AG, et al. G∗Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 ; 39: 175-191
10. Fox BR. Kinetics and mechanism of the Griess reaction. Anal Chem. 1979 ; 51: 1493-1502
11. Gergerlioglu HS, Savas HA, Bulbul F, et al. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Progr Neuropsychopharmacol Biol Psychiatry. 2007 ; 31: 697-702
12. Goldstein BI, Kemp DE, Soczynska JK, et al. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: A systematic review of the literature. J Clin Psychiatry. 2009 ; 70: 1078-1090
13. Hoogman M, Aarts E, Zwiers M, et al. Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects. Am J Psychiatry. 2011 ; 168: 1099-1106
14. Hopper R, Lancaster B, Garthwaite J. On the regulation of NMDA receptors by nitric oxide. Eur J Neurosci. 2004 ; 19: 1675-1682
15. Kanwar JR, Kanwar RK, Burrow H, et al. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr Med Chem. 2009 ; 16: 2373-2394
16. Kiss JP, Vizi ES. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci. 2001 ; 24: 211-215
17. Kurrikoff T, Lesch KP, Kiive E, et al. Association of a functional variant of the nitric oxide synthase 1 gene with personality, anxiety, and depressiveness. Dev Psychopathol. 2012 ; 24: 1225-1235
18. Margraf J Diagnostisches Kurzinterview bei psychischen Störungen: Mini-DIPS. Berlin, Heidelberg, New York: Springer Verlag ; 1994 :
19. Marzinzig M, Nussler AK, Stadler J, et al. Improved methods to measure end products of nitric oxide in biological fluids: Nitrite, nitrate, and S-nitrosothiols. Nitric Oxide Biol Chem. 1997 ; 1: 177-189
20. McCullumsmith RE, Kristiansen LV, Beneyto M, et al. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res. 2007 ; 1127: 108-118
21. Molero L, Garcia-Duran M, Diaz-Recasens J, et al. Expression of estrogen receptor subtypes and neuronal nitric oxide synthase in neutrophils from women and men: Regulation by estrogen. Cardiovasc Res. 2002 ; 56: 43-51
22. Nakayama M, Yasue H, Yoshimura M, et al. T-786->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999 ; 99: 2864-2870
23. Nelson RJ, Trainor BC, Chiavegatto S, et al. Pleiotropic contributions of nitric oxide to aggressive behavior. Neurosci Biobehav Rev. 2006 ; 30: 346-355
24. Reif A, Grunblatt E, Herterich S, et al. Association of a functional NOS1 promoter repeat with Alzheimer's disease in the VITA cohort. J Alzheimers Dis. 2011a ; 23: 327-333
25. Reif A, Herterich S, Strobel A, et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry. 2006a ; 11: 286-300
26. Reif A, Jacob CP, Rujescu D, et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry. 2009 ; 66: 41-50
27. Reif A, Kiive E, Kurrikoff T, et al. A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity. Psychopharmacology (Berl). 2011b ; 214: 239-248
28. Reif A, Schmitt A, Fritzen S, et al. Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci. 2004 ; 20: 885-895
29. Reif A, Strobel A, Jacob CP, et al. A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder. Int J Neuropsychopharmacol. 2006b ; 9: 13-20
30. Retz-Junginger P, Retz W, Blocher D, et al. [Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults]. Nervenarzt. 2002 ; 73: 830-838
31. Sandrim VC, De Syllos RW, Lisboa HR, et al. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide. 2007 ; 16: 348-355
32. Savas HA, Gergerlioglu HS, Armutcu F, et al. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes. World J Biol Psychiatry. 2006 ; 7: 51-55
33. Savas HA, Herken H, Yurekli M, et al. Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology. 2002 ; 45: 57-61
34. Selek S, Savas HA, Gergerlioglu HS, et al. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord. 2008a ; 107: 89-94
35. Selek S, Savas HA, Gergerlioglu HS, et al. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol. 2008b ; 79: 256-259
36. Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res. 1994 ; 31: 131-143
37. Sorte K, Basak A. Development of a modified copper-cadmium reduction method for rapid assay of total nitric oxide. Anal Methods. 2010 ; 2: 944-947
38. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: Nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ Res. 2001 ; 89: 224-236
39. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002 ; 3: RESEARCH0034
40. Venturelli E, Galimberti D, Lovati C, et al. The T-786C NOS3 polymorphism in Alzheimer's disease: Association and influence on gene expression. Neurosci Lett. 2005 ; 382: 300-303
41. Volke V, Wegener G, Bourin M, et al. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res. 2003 ; 140: 141-147
42. Weber H, Kittel-Schneider S, Gessner A, et al. Cross-disorder analysis of bipolar risk genes: Further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology. 2011 ; 36: 2076-2085
43. Weber H, Klamer D, Freudenberg F, et al. The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: Further evidence and meta-analysis. Eur Neuropsychopharmacol. 2014 ; 24: 65-85
44. Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry. 2004 ; 61: 649-657
45. Yanik M, Vural H, Tutkun H, et al. The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci. 2004 ; 254: 43-47
46. Yao JK, Leonard S, Reddy RD. Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr Bull. 2004 ; 30: 923-934
47. Yoshimura T, Moon TC, Laurent CD, et al. Expression of nitric oxide synthases in leukocytes in nasal polyps. Ann Allergy Asthma Immunol. 2012 ; 108: 172-177
48. Zarate CA, Brutsche NE, Ibrahim L, et al. Replication of ketamine's antidepressant efficacy in bipolar depression: A randomized controlled add-on trial. Biol Psychiatry. 2012 ; 71: 939-946